|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 30, 2016 ) Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. Its administration includes increasing the doses of allergen extracts over a span of time either through injections or sublingual tablets and drops.
Allergies occur when a foreign substance, which is mostly harmless, reacts with the immune system. These foreign substances are called allergens. Some allergens that affect the immune system are animal dander, dust mite, pollens, cockroach, and mold. Animal dander, dust mite, and mold cause indoor allergies.
There are various types of allergies, including rhinitis, asthma, eye allergy, and skin allergy. Sometimes, severe allergies can lead to death, as the severity of these allergic reactions interfere with the proper function of organs. For instance, allergic rhinitis and asthma cause the lungs to function poorly.
Publisher's analysts forecast the global allergy immunotherapies market to grow at a CAGR of 7.3% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-allergy-immunotherapies-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the global allergy immunotherapies market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat allergic diseases such as allergic rhinitis and allergic asthma. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
- Europe
- North America
- ROW
Publisher's report, Global Allergy Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- ALK-Abello
- Stallergenes
- Merck Group
- Allergy Therapeutics
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001303269/sample
Other prominent vendors
- Adamis Pharmaceuticals
- Aimmune Therapeutics
- Anergis
- ASIT biotech
- Biomay
- Circassia
- DBV Technologies
- Genentech
- HAL Allergy
- Laboratorios LETI
- Mitsubishi Tanabe Pharma
- Nycomed
- Sementis
- Shionogi
- Torii
- Tunitas Therapeutics
- VentiRx Pharmaceuticals
- Verona Pharma
Market driver
- Presence of high unmet medical needs
- For a full, detailed list, view our report
Market challenge
- Poor patient adherence and high dropout rates
- For a full, detailed list, view our report
Market trend
- Advent of SPIRE
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001303269/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
